Literature DB >> 19141388

Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant?

Roberta Mazzucchelli1, Francesca Barbisan, Marina Scarpelli, Antonio Lopez-Beltran, Theodorus H van der Kwast, Liang Cheng, Rodolfo Montironi.   

Abstract

Cystoprostatectomy specimens obtained from patients with bladder cancer provide a unique opportunity to assess the features of silent prostate adenocarcinoma (PCa). The whole-mount prostate sections of 248 totally embedded and consecutively examined radical cystoprostatectomy (RCP) specimens were reviewed to determine the incidence and features of incidentally detected PCa. PCa was considered clinically significant if any of the following criteria were present: total tumor volume, 0.5 cc or more; Gleason grade, 4 or more; extraprostatic extension; seminal vesicle invasion; lymph node metastasis (of PCa); or positive surgical margins. PCa was present in 123 (49.6%) of 248 specimens. Features were as follows: acinar adenocarcinoma, 123 (100.0%); peripheral zone location, 98 (79.7%); pT2a, 96 (78.0%); pT2b, 11 (8.9%); pT2c, 9 (7.3%); pT3a, 5 (4.1%); pT3b, 2 (1.6%); pT4, 0 (0.0%); Gleason score 6 or less, 107 (87.0%); negative margins, 119 (96.7%); pN0 for PCa, 123 (100.0%); and tumor volume less than 0.5 cc, 116 (94.3%). Of the 123 incidentally detected cases of PCa, 100 (81.3%) were considered clinically insignificant. Incidentally detected PCa is frequently observed in RCP. The majority are clinically insignificant.

Entities:  

Mesh:

Year:  2009        PMID: 19141388     DOI: 10.1309/AJCP4OCYZBAN9TJU

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  18 in total

1.  Clinical Significance of Incidental Prostatic Carcinoma on Radical Cystectomy Histology Specimens: a Clinicopathological and Survival Analysis.

Authors:  Dharma Ram; Suhas K Rajappa; Sudhir Rawal; Amitabh Singh; Kailash Chand Sharma; Ajay Kumar Dewan
Journal:  Indian J Surg Oncol       Date:  2018-04-21

2.  Incidental prostate cancer prevalence at radical cystoprostatectomy--importance of the histopathological work-up.

Authors:  C Wetterauer; M Weibel; J R Gsponer; T Vlajnic; T Zellweger; S Bütikofer; G Müller; H Püschel; A Bachmann; T C Gasser; L Bubendorf; C A Rentsch
Journal:  Virchows Arch       Date:  2014-10-01       Impact factor: 4.064

3.  Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens.

Authors:  H M Fritsche; A Aziz; F Eder; W Otto; S Denzinger; W F Wieland; M May; F Hofstädter; A Hartmann; M Burger
Journal:  Virchows Arch       Date:  2012-10-09       Impact factor: 4.064

Review 4.  Concomitant bladder cancer and prostate cancer: challenges and controversies.

Authors:  Antonio Lopez-Beltran; Liang Cheng; Francesco Montorsi; Maria Scarpelli; Maria R Raspollini; Rodolfo Montironi
Journal:  Nat Rev Urol       Date:  2017-08-16       Impact factor: 14.432

5.  Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases.

Authors:  Pietro Pepe; Filippo Fraggetta; Antonio Galia; Paolo Panella; Michele Pennisi; Maurizio Colecchia; Francesco Aragona
Journal:  Int Urol Nephrol       Date:  2014-02-01       Impact factor: 2.370

Review 6.  Defining the threshold for significant versus insignificant prostate cancer.

Authors:  Theo H Van der Kwast; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

7.  The incidence of prostate cancer and urothelial cancer in the prostate in cystoprostatectomy specimens in a tertiary care Canadian centre.

Authors:  Sri Sivalingam; Darrel Drachenberg
Journal:  Can Urol Assoc J       Date:  2013 Jan-Feb       Impact factor: 1.862

8.  Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia.

Authors:  Xue-Qin Zhang; Xiang-Rong Yu; Zhong-Li Du; Xiao-Fen Miao; Jian Lu; Quan Zhou
Journal:  Oncol Lett       Date:  2018-02-27       Impact factor: 2.967

9.  Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies.

Authors:  Sven Gunia; Stefan Koch; Matthias May; Manfred Dietel; Andreas Erbersdobler
Journal:  Virchows Arch       Date:  2009-03-20       Impact factor: 4.064

10.  Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma.

Authors:  Laura Macías-García; Haydee De la Hoz-Herazo; Antonio Robles-Frías; María J Pareja-Megía; Juan López-Garrido; José I López
Journal:  Diagn Pathol       Date:  2012-10-30       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.